Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 4:55 pm Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Nantahala Capital Management LLC | 4,611,302 7.5% | 1,797,742 (+63.90%) | View |
2023-02-14 4:54 pm Sale | 13G | UNIQURE N V QURE | Nantahala Capital Management LLC | 3,887,939 8.3% | -581,274 (-13.01%) | View |
2023-02-14 4:54 pm Sale | 13G | IMAX CORPORATION IMAX | Nantahala Capital Management LLC | 4,988,189 8.9% | -209,301 (-4.03%) | View |
2023-02-14 4:52 pm Sale | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management LLC | 1,207,416 8% | -39,340 (-3.16%) | View |
2023-02-14 4:51 pm Purchase | 13G | LUXFER HOLDINGS PLC SHS LXFR | Nantahala Capital Management LLC | 2,452,319 9% | 334,086 (+15.77%) | View |
2023-02-14 4:51 pm Purchase | 13G | RED VIOLET INC RDVT | Nantahala Capital Management LLC | 1,275,088 9.2% | 251,629 (+24.59%) | View |
2023-02-14 4:50 pm Sale | 13G | TRAVELCENTERS AMER INC TA | Nantahala Capital Management LLC | 1,031,394 6.9% | -241,176 (-18.95%) | View |
2023-02-14 4:49 pm Purchase | 13G | BIOVENTUS INC BVS | Nantahala Capital Management LLC | 3,168,574 5.1% | 3,168,574 (New Position) | View |
2023-02-14 4:48 pm Purchase | 13G | DRIVE SHACK INC DS | Nantahala Capital Management LLC | 6,500,000 7% | 6,500,000 (New Position) | View |
2023-02-14 4:48 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Nantahala Capital Management LLC | 2,220,830 7% | 2,220,830 (New Position) | View |
2023-02-14 4:47 pm Sale | 13G | FINTECH ACQUISITION CORP V CL FTCV | Nantahala Capital Management LLC | 0 0% | -1,324,763 (Position Closed) | View |
2023-02-14 4:47 pm Sale | 13G | AKUMIN INC AKU | Nantahala Capital Management LLC | 2,206,960 2.5% | -4,113,780 (-65.08%) | View |
2023-02-14 4:46 pm Sale | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Nantahala Capital Management LLC | 975,705 1.4% | -2,074,854 (-68.02%) | View |
2023-02-14 4:46 pm Sale | 13G | DXP ENTERPRISES INC- DXPE | Nantahala Capital Management LLC | 338,090 1.8% | -885,168 (-72.36%) | View |
2023-02-14 4:46 pm Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | Nantahala Capital Management LLC | 438,055 1.4% | -2,323,605 (-84.14%) | View |
2023-02-14 4:45 pm Sale | 13G | INSU ACQUISITION CORP III IIII | Nantahala Capital Management LLC | 0 0% | -1,333,332 (Position Closed) | View |
2022-12-28 4:03 pm Purchase | 13G | RUMBLEON INC RMBL | Nantahala Capital Management LLC | 1,476,463 9.2% | 1,476,463 (New Position) | View |
2022-12-14 4:06 pm Sale | 13G | AVENUE THERAPEUTICS INC NE ATXI | Nantahala Capital Management LLC | 0 0% | -1,453,166 (Position Closed) | View |
2022-12-14 4:05 pm Sale | 13G | ZOVIO INC ZVO | Nantahala Capital Management LLC | 0 0% | -2,980,767 (Position Closed) | View |
2022-12-02 5:21 pm Sale | 13G | CUE BIOPHARMA INC CUE | Nantahala Capital Management LLC | 93,297 0.3% | -2,446,403 (-96.33%) | View |